Cargando…
Clozapine-Treatment-Resistant Schizophrenia Successfully Managed with Brexpiprazole Combination Therapy: Two Case Reports
INTRODUCTION: Clozapine has proven to have a unique efficacy on treatment-resistant schizophrenia (TRS). Nevertheless, studies show that 47%-63% of clozapine-treated patients may fail to respond after around 12-years of treatment (CRS). Several augmentation strategies have been proven to be effectiv...
Autores principales: | Orsolini, L., Tempia Valenta, S., Bellagamba, S., Salvi, V., Volpe, U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566962/ http://dx.doi.org/10.1192/j.eurpsy.2022.903 |
Ejemplares similares
-
Augmentation strategy fluoxetine and lurasidone in the treatment of OCD with comorbid Restrictive Anorexia: a case report
por: Orsolini, L., et al.
Publicado: (2022) -
Modern-type depression and web-based psychopathology in a cohort of Italian university students
por: Orsolini, L., et al.
Publicado: (2022) -
Boredom, loneliness and modern type depression in a cohort of Italian university students
por: Orsolini, L., et al.
Publicado: (2022) -
Digital Psychiatry in the COVID-19 Era: the First Italian Cross-National Survey
por: Orsolini, L., et al.
Publicado: (2022) -
Brexpiprazole augmentation in a clozapine-resistant young schizophrenic patient: a successful case report.
por: Martiadis, V., et al.
Publicado: (2023)